CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (UNAUDITED) - USD ($) $ in Thousands | Total | Common Stock | Accumulated Deficit |
Balance, beginning of period at Feb. 01, 2020 | $ 76,955 | $ 172,885 | $ (95,930) |
Balance, beginning of period (in shares) at Feb. 01, 2020 | | 13,955,826 | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | |
Employee stock purchases | 35 | $ 35 | |
Employee stock purchases (in shares) | | 34,999 | |
Restricted stock issued | | 32,341 | |
Net share settlement of stock options and restricted stock units | (8) | $ (8) | |
Net share settlement of stock options and restricted stock units (in shares) | | (8,663) | |
Stock-based compensation expense | 307 | $ 307 | |
Net income (loss) | (7,438) | | (7,438) |
Balance, end of period at May. 02, 2020 | 69,851 | $ 173,219 | (103,368) |
Balance, end of period (in shares) at May. 02, 2020 | | 14,014,503 | |
Balance, beginning of period at Feb. 01, 2020 | 76,955 | $ 172,885 | (95,930) |
Balance, beginning of period (in shares) at Feb. 01, 2020 | | 13,955,826 | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | |
Exercise of stock options | $ 12 | | |
Repurchase and retirement of common stock (in shares) | 0 | | |
Net income (loss) | $ (4,445) | | |
Balance, end of period at Oct. 31, 2020 | $ 73,417 | $ 173,792 | (100,375) |
Balance, end of period (in shares) at Oct. 31, 2020 | 14,255,596 | 14,255,596 | |
Balance, beginning of period at May. 02, 2020 | $ 69,851 | $ 173,219 | (103,368) |
Balance, beginning of period (in shares) at May. 02, 2020 | | 14,014,503 | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | |
Restricted stock issued | | 230,688 | |
Net share settlement of stock options and restricted stock units | (5) | $ (5) | |
Net share settlement of stock options and restricted stock units (in shares) | | (5,110) | |
Stock-based compensation expense | 329 | $ 329 | |
Net income (loss) | (9,363) | | (9,363) |
Balance, end of period at Aug. 01, 2020 | 60,812 | $ 173,543 | (112,731) |
Balance, end of period (in shares) at Aug. 01, 2020 | | 14,240,081 | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | |
Exercise of stock options | 12 | $ 12 | |
Exercise of stock options (in shares) | | 1,464 | |
Restricted stock issued | | 18,575 | |
Net share settlement of stock options and restricted stock units | (39) | $ (39) | |
Net share settlement of stock options and restricted stock units (in shares) | | (4,524) | |
Stock-based compensation expense | $ 276 | $ 276 | |
Repurchase and retirement of common stock (in shares) | 0 | | |
Net income (loss) | $ 12,356 | | 12,356 |
Balance, end of period at Oct. 31, 2020 | $ 73,417 | $ 173,792 | (100,375) |
Balance, end of period (in shares) at Oct. 31, 2020 | 14,255,596 | 14,255,596 | |
Balance, beginning of period at Jan. 30, 2021 | $ 94,922 | $ 174,391 | (79,469) |
Balance, beginning of period (in shares) at Jan. 30, 2021 | 14,292,250 | 14,292,250 | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | |
Exercise of stock options | $ 52 | $ 52 | |
Exercise of stock options (in shares) | | 10,669 | |
Restricted stock issued | | 30,087 | |
Net share settlement of stock options and restricted stock units | (257) | $ (257) | |
Net share settlement of stock options and restricted stock units (in shares) | | (11,339) | |
Stock-based compensation expense | 232 | $ 232 | |
Repurchase and retirement of common stock | (1,356) | | (1,356) |
Repurchase and retirement of common stock (in shares) | | (47,350) | |
Net income (loss) | 1,719 | | 1,719 |
Balance, end of period at May. 01, 2021 | 95,312 | $ 174,418 | (79,106) |
Balance, end of period (in shares) at May. 01, 2021 | | 14,274,317 | |
Balance, beginning of period at Jan. 30, 2021 | $ 94,922 | $ 174,391 | (79,469) |
Balance, beginning of period (in shares) at Jan. 30, 2021 | 14,292,250 | 14,292,250 | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | |
Exercise of stock options | $ 146 | | |
Repurchase and retirement of common stock (in shares) | (1,414,642) | | |
Net income (loss) | $ 9,574 | | |
Balance, end of period at Oct. 30, 2021 | $ 75,763 | $ 175,479 | (99,716) |
Balance, end of period (in shares) at Oct. 30, 2021 | 13,007,409 | 13,007,409 | |
Balance, beginning of period at May. 01, 2021 | $ 95,312 | $ 174,418 | (79,106) |
Balance, beginning of period (in shares) at May. 01, 2021 | | 14,274,317 | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | |
Exercise of stock options | 94 | $ 94 | |
Exercise of stock options (in shares) | | 20,168 | |
Restricted stock issued | | 79,775 | |
Net share settlement of stock options and restricted stock units | (73) | $ (73) | |
Net share settlement of stock options and restricted stock units (in shares) | | (7,582) | |
Stock-based compensation expense | 651 | $ 651 | |
Repurchase and retirement of common stock | (12,008) | | (12,008) |
Repurchase and retirement of common stock (in shares) | | (561,548) | |
Net income (loss) | 626 | | 626 |
Balance, end of period at Jul. 31, 2021 | 84,602 | $ 175,090 | (90,488) |
Balance, end of period (in shares) at Jul. 31, 2021 | | 13,805,130 | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | |
Restricted stock issued | | 10,606 | |
Net share settlement of stock options and restricted stock units | (49) | $ (49) | |
Net share settlement of stock options and restricted stock units (in shares) | | (2,583) | |
Stock-based compensation expense | 438 | $ 438 | |
Repurchase and retirement of common stock | $ (16,457) | | (16,457) |
Repurchase and retirement of common stock (in shares) | (805,744) | (805,744) | |
Net income (loss) | $ 7,229 | | 7,229 |
Balance, end of period at Oct. 30, 2021 | $ 75,763 | $ 175,479 | $ (99,716) |
Balance, end of period (in shares) at Oct. 30, 2021 | 13,007,409 | 13,007,409 | |